Markets:

Overview

News

Currencies

International

Treasuries

Oragenics Inc. Common Stock (NY:OGEN)

0.5318 -0.0082 (-1.52%)

Streaming Delayed Price Updated: 11:47 AM EDT, Aug 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Oragenics Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Oragenics to Participate in the 2022 BioFlorida Annual Conference

October 24, 2022

From Oragenics, Inc.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

October 20, 2022

It's time for another dive into the biggest pre-market stock movers as we get a start on Thursday trading with the latest news!

Via InvestorPlace

Oragenics Issues Letter to Shareholders

September 30, 2022

From Oragenics, Inc.

Via Business Wire

Oragenics Announces Favorable Preliminary Toxicology Data for Intranasal COVID-19 Vaccine Candidate

August 24, 2022

From Oragenics, Inc.

Via Business Wire

Why Bed Bath & Beyond Is Trading Higher By 12%; Here Are 26 Stocks Moving Premarket ↗

August 24, 2022

Gainers Bird Global, Inc. (NYSE: BRDS) shares rose 25.2% to $0.54 in pre-market trading. Bird secured permit extensions and expanded to new U.S. cities.

Via Benzinga

Oragenics Appoints Seasoned Vaccine Executive Kimberly Murphy as President and Chief Executive Officer

June 23, 2022

From Oragenics, Inc.

Via Business Wire

Oragenics Announces Publication of Positive Data for its NT-CoV2-1 Intranasal COVID-19 Vaccine Candidate in Scientific Reports

June 14, 2022

From Oragenics, Inc

Via Business Wire

Oragenics Issues Letter to Shareholders

May 17, 2022

From Oragenics, Inc.

Via Business Wire

The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis ↗

April 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Oragenics's Earnings: A Preview ↗

April 26, 2022

Oragenics (AMEX:OGEN) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Oragenics will...

Via Benzinga

Oragenics to Participate at the World Vaccine Congress Washington 2022

April 18, 2022

From Oragenics, Inc.

Via Business Wire

Earnings Scheduled For April 27, 2022 ↗

April 27, 2022

Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter.

Via Benzinga

Oragenics Extends Collaboration to Develop Vaccines against Future Variants of Coronaviruses

April 06, 2022

From Oragenics, Inc.

Via Business Wire

68 Biggest Movers From Yesterday ↗

April 05, 2022

Gainers GBS Inc. (NASDAQ: GBS) jumped 68% to settle at $1.31 on Monday. Zacks Small-Cap Research issued a note on GBS with an $8 valuation. Aterian, Inc. (NASDAQ: ATER) shares...

Via Benzinga

Executives Buy Around $5.5M Of 3 Penny Stocks ↗

April 04, 2022

US crude oil futures traded higher on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the...

Via Benzinga

4 Penny Stocks Insiders Are Buying ↗

March 31, 2022

US crude oil futures traded sharply lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation

March 25, 2022

From Oragenics, Inc.

Via Business Wire

Oragenics Initiates a Pivotal IND-Enabling Toxicology Study on its Intranasal COVID-19 Vaccine Candidate, NT-CoV2-1

March 22, 2022

From Oragenics, Inc.

Via Business Wire

Oragenics Partners With KBI Biopharma To Produce Material For Its Intranasal COVID-19 Vaccine Candidate ↗

March 10, 2022

Oragenics Inc (NYSE: OGEN) has entered into an agreement with KBI Biopharma Inc for the process transfer, process optimization, and cGMP manufacturing of...

Via Benzinga

Oragenics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum

January 26, 2022

From Oragenics, Inc.

Via Business Wire

5 Stocks Insiders Are Buying Right Now ↗

January 07, 2022

Several stocks that insiders are buying are worth watching as we enter the new year. This week, that list includes F, CRCT, CHWY and OGEN.

Via InvestorPlace

45 Biggest Movers From Yesterday ↗

January 05, 2022

Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced...

Via Benzinga

Nvidia Omniverse: 14 Things for NVDA Stock Investors to Know About the Metaverse Project ↗

January 04, 2022

Nvidia (NVDA) is bringing its metaverse project, titled Omniverse, out of beta and letting creators take advantage of the service.

Via InvestorPlace

Mid-Day Market Update: Nasdaq Dips 250 Points; TherapeuticsMD Shares Surge ↗

January 04, 2022

Midway through trading Tuesday, the Dow traded up 0.66% to 36,827.65 while the NASDAQ fell 1.63% to 15,574.50. The S&P also fell, dropping 0.08% to 4,792.93. The U.S. has the...

Via Benzinga

OGEN Stock Alert: The Insider Buying Giving Oragenics Shares Some Oomph Today ↗

January 04, 2022

Oragenics (OGEN) stock is rising higher on Tuesday following news of massive insider buying at the development-stage company.

Via InvestorPlace

34 Stocks Moving In Tuesday's Mid-Day Session ↗

January 04, 2022

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women...

Via Benzinga

23 Stocks Moving in Tuesday's Pre-Market Session ↗

January 04, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and corporate update. NeuroBo Pharmaceuticals, Inc...

Via Benzinga

Oragenics Extends Collaboration with NRC Canada For Omicron-Specific Vaccine ↗

December 20, 2021

Oragenics Inc (NYSE: OGEN) has extended a licensing and collaboration agreement with the National Research Council of Canada (NRC) to enable Oragenics to pursue an...

Via Benzinga

Oragenics Extends Collaboration with the National Research Council of Canada to Develop Vaccine against the Omicron Variant

December 20, 2021

From Oragenics, Inc.

Via Business Wire

Oragenics to Participate in Virtual Fireside Chat Hosted by Alliance Global Partners

December 09, 2021

From Oragenics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Oragenics Inc. Common Stock (NY:OGEN)

All News about Oragenics Inc. Common Stock

Starting at /week.